Quanterix Corp reports results for the quarter ended December 31 - Earnings Summary

• Quanterix Corp QTRX.OQ reported a quarterly adjusted loss of 49 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of four analysts for the quarter was for a loss of 45 cents per share. Wall Street expected results to range from -67 cents to -27 cents per share.

• Revenue rose 24.7% to $43.86 million from a year ago; analysts expected $38.14 million.

• Quanterix Corp's reported EPS for the quarter was a loss of 49 cents​.

• The company reported a quarterly loss of $23.12 million.

• Quanterix Corp shares had risen by 3.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for Quanterix Corp is $7.50, about 15.6% above its last closing price of $6.33

This summary was machine generated from LSEG data March 3 at 12:19 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)